A Study of Methylprednisolone in People Having Liver Surgery

The purpose of this study is to test whether receiving methylprednisolone before surgery will reduce the side effects of having surgery, such as infections and longer hospital stays.

Trial Details

NCT ID
NCT07507643
Phase
PHASE3
Sponsor
Memorial Sloan Kettering Cancer Center
Status
RECRUITING
Cancer Type
Liver Cancer
Interventions
  • Methylprednisolone
Locations (sample)
  • Chicago, Illinois, United States|41.85003,-87.65005
  • Chicago, Illinois, United States|41.85003,-87.65005
  • Indianapolis, Indiana, United States|39.76838,-86.15804
  • Iowa City, Iowa, United States|41.66113,-91.53017
  • Lexington, Kentucky, United States|37.98869,-84.47772

Key Eligibility Criteria

  • Age ≥18 years at the time of consent.
  • Scheduled to undergo elective major hepatectomy (defined by CPT codes 47122 \[trisegmentectomy\], 47125 \[total left hepatectomy\], or 47130 \[tota…
  • In addition to major hepatectomy, as defined above, patients may undergo additional partial hepatectomy or operative ablation.

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Liver Cancer Trials on Trialify →